Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine vs Cyclophosphamide in Haploidentical BMT
NCT02996773Phase 1Completed
- Sponsor
- University of Arizona
- Start
- Nov 2016
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of bendamustine in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and 10 more, sponsored by University of Arizona. Started Nov 2016; status: completed.
02
Drugs
bendamustine
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)chronic myelogenous leukemia (CML)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT02996773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02996773.